BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28273387)

  • 1. Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States.
    Young K; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
    J Viral Hepat; 2017 Sep; 24(9):789-796. PubMed ID: 28273387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United States.
    Young K; Liu B; Bhuket T; Gish RG; Wong RJ
    J Viral Hepat; 2019 Mar; 26(3):350-361. PubMed ID: 30412318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
    Yang JD; Larson JJ; Watt KD; Allen AM; Wiesner RH; Gores GJ; Roberts LR; Heimbach JA; Leise MD
    Clin Gastroenterol Hepatol; 2017 May; 15(5):767-775.e3. PubMed ID: 28013117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients.
    Aguilar M; Liu B; Holt EW; Bhuket T; Wong RJ
    Liver Int; 2016 Aug; 36(8):1167-75. PubMed ID: 26858016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoalbuminemia is Associated With Significantly Higher Liver Transplant Waitlist Mortality and Lower Probability of Receiving Liver Transplant.
    Ahn J; Sundaram V; Ayoub WS; Frenette C; Wong RJ
    J Clin Gastroenterol; 2018; 52(10):913-917. PubMed ID: 29356783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.
    Campsen J; Zimmerman M; Trotter J; Hong J; Freise C; Brown R; Cameron A; Ghobrial M; Kam I; Busuttil R; Saab S; Holt C; Emond J; Stiles J; Lukose T; Chang M; Klintmalm G
    Liver Transpl; 2013 Sep; 19(9):1020-9. PubMed ID: 23852663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
    Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
    Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.
    Ahn J; Liu B; Bhuket T; Wong RJ
    Dig Dis Sci; 2017 Apr; 62(4):1051-1057. PubMed ID: 28168576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
    Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing frequency and improved outcomes of hepatitis C-related liver transplantation in the era of direct-acting antivirals - a retrospective cohort study.
    Arora SS; Axley P; Ahmed Z; Satapathy SK; Wong R; Kuo YF; Singal AK
    Transpl Int; 2019 Aug; 32(8):854-864. PubMed ID: 30866110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes.
    Burra P; Germani G; Adam R; Karam V; Marzano A; Lampertico P; Salizzoni M; Filipponi F; Klempnauer JL; Castaing D; Kilic M; Carlis LD; Neuhaus P; Yilmaz S; Paul A; Pinna AD; Burroughs AK; Russo FP
    J Hepatol; 2013 Feb; 58(2):287-96. PubMed ID: 23099188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
    Flemming JA; Kim WR; Brosgart CL; Terrault NA
    Hepatology; 2017 Mar; 65(3):804-812. PubMed ID: 28012259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States.
    Kwong AJ; Ghaziani TT; Yao F; Sze D; Mannalithara A; Mehta N
    Clin Gastroenterol Hepatol; 2022 May; 20(5):1142-1150.e4. PubMed ID: 34358718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
    Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
    Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
    Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.
    ViganĂ² M; Bhoori S; Lampertico P; Donato MF; Iavarone M; Grossi G; Facciorusso A; Caccamo L; Rossi G; Colombo M; Mazzaferro V
    Liver Int; 2015 Sep; 35(9):2187-93. PubMed ID: 25809541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.